Rosiglitazone (4 mg, enema treatment once daily for 14 days) increased the expression of PPARγ in the inflamed colonic epithelium and exerted local anti‐inflammatory effects in the guts of patients with IBD.34 This evidence concerns the gene PPARG and inflammatory bowel disease.